Comparative Analysis of the Anxiolytic Effects of 3-Hydroxypyridine and Succinic Acid Derivatives
- 21 April 2015
- journal article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 158 (6) , 756-761
Abstract
Threefold administration of 3-hydroxypyridine derivatives emoxipine and mexidol in optimal doses corresponding to the therapeutic dose range for humans produced an anxiolytic effect and stimulated risk behavior in the elevated plus maze test in rats. These effects were most pronounced after injection of 3-hydroxypyridine derivative emoxipine. Combination of 3-hydroxypyridine cation and succinate anion in the mexidol structure led to attenuation of the anxiolytic effect and less pronounced stimulation of the risk behavior. By the anxiolytic effect and induction of risk behavior, emoxipine and mexidol were close to the reference substance amitriptyline. Reamberin, a succinic acid derivative, had no pronounced tranquilizing properties, but risk behavior induction was similar to that produced by mexidol. In contrast to other test agents, the reference substance α-lipoic acid produced anxiogenic effects and suppressed risk behavior. The obtained results suggest that Russian-made 3-hydroxypyridine derivatives emoxipine and mexidol are promising preparations for the treatment of anxiety disorders.Keywords
This publication has 4 references indexed in Scilit:
- Effects of 3-Hydroxypyridine Derivatives and Succinic Acid on Endometrial Leukocyte Infiltration, Cytokinemia and Related Affective Symptoms during Exacerbation of the Chronic Inflammation of the Uterus and AdnexaBulletin of Experimental Biology and Medicine, 2014
- Anti-Alcohol and Anxiolytic Properties of a New Chemical Entity, GET73Frontiers in Psychiatry, 2012
- Methods of Behavior Analysis in Neuroscience2008
- The use of the elevated plus maze as an assay of anxiety-related behavior in rodentsNature Protocols, 2007